Daiichi Sankyo Company, Limited (4568.T) stock analysis
In our weekly check, Daiichi Sankyo Company, Limited is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 3, red flags: 4.
About Daiichi Sankyo Company, Limited
Daiichi Sankyo Company, Limited is a Healthcare company (Drug Manufacturers - General) based in Japan, listed on JPX as 4568.T.
What our checks show for 4568.T
Red flags
- Free cash flow is negative (-0.1% of revenue): the business spends more cash than it brings in.
- The stock has fallen as much as 70% from a peak. Would you have held through that?
- Recovering from its deepest fall took about 5.1 years.
- Pay in shares equals 0% of free cash flow: it dilutes shareholders.
Warning signs
- Operating cash flow is only 0.55x net profit: part of the reported profit does not arrive as cash.
- The price swings a lot: 38% annual volatility. Expect large ups and downs.
- Return on capital (ROCE) is only 5.9%.
Strengths
- Debt is low: 0.29x equity.
- Operating profit covers interest 20 times over.
- The net margin rose by 4.5 points over 5 years, to 10.9%.
- The gross margin is 68.5% and has risen by 2.3 points: pricing power is holding.
- Analysts expect earnings per share to grow about 11% a year over the next years.
- Analysts expect the net margin to improve by 2.1 points from today's 10.9%.
Next earnings report: 2026-10-30
Similar companies
4503.T · 4578.T · 4519.T · LLY · JNJ
Questions
What grade does Daiichi Sankyo Company, Limited (4568.T) have?
In our weekly check, Daiichi Sankyo Company, Limited is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 3, red flags: 4. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of 4568.T stock?
This week's biggest flags for Daiichi Sankyo Company, Limited: Weak free cash flow, Deep past fall, Slow recovery after falls. In total 7 of 25 checks show a warning or a red flag.
What does Daiichi Sankyo Company, Limited do?
Daiichi Sankyo Company, Limited is a Healthcare company (Drug Manufacturers - General) based in Japan, listed on JPX as 4568.T.
When does Daiichi Sankyo Company, Limited report earnings next?
The next earnings report is expected on 2026-10-30. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-10-24
Open the full analysis